Review Article
Recent Developments in Diabetic Retinal Neurodegeneration: A Literature Review
Table 1
Novel therapeutic approaches to diabetic retinal neurodegeneration in experimental studies.
| Anti-inflammatory substances | Antioxidants | Neurotrophins and other neuroprotective factors | Mixed or unknown mechanisms |
| Alpha-1-antitrypsin | Fenofibrate and other PPARα agonists | Somatostatin | Flavonoids and other nutraceuticals | Citicoline | Inhibitors of protein tau hyperphosphorylation: ginsenoside Rg1 Notoginsenoside R1 siRNA | Ciliary neurotrophic factor | Angiotensin II type 1 receptor blockers | Fluocinolone acetonide | Spermine oxidase inhibitors | Sigma1 receptor | Angiotensin-converting enzyme 2 activators | | Caffeic acid alkyl amide derivatives | Synthetic microneurotrophin BNN27 | GLP-1 receptor agonists | | Taurine | Brain-derived neurotrophic factor | Lamivudine | | Gabapentin | Eicosapentaenoic acid ethyl ester | Endothelin-1 receptor antagonists | | Acrolein-scavenging 2-HDP | Intravitreal bone marrow CD133+ stem cells transplantation | Intraocular pressure-lowering agents | | Astaxanthin | | |
|
|